- Home
- UGRO vs DRMA Comparison
UGRO vs DRMA Comparison
Compare UGRO & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- DRMA
- Stock Information
- Founded
- UGRO 2014
- DRMA 2014
- Country
- UGRO United States
- DRMA United States
- Employees
- UGRO N/A
- DRMA N/A
- Industry
- UGRO Industrial Specialties
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- DRMA Health Care
- Exchange
- UGRO Nasdaq
- DRMA Nasdaq
- Market Cap
- UGRO 5.5M
- DRMA 4.5M
- IPO Year
- UGRO N/A
- DRMA 2021
- Fundamental
- Price
- UGRO $0.39
- DRMA $0.75
- Analyst Decision
- UGRO Strong Buy
- DRMA Strong Buy
- Analyst Count
- UGRO 1
- DRMA 1
- Target Price
- UGRO $3.00
- DRMA $3.00
- AVG Volume (30 Days)
- UGRO 117.3K
- DRMA 70.9K
- Earning Date
- UGRO 06-17-2025
- DRMA 05-14-2025
- Dividend Yield
- UGRO N/A
- DRMA N/A
- EPS Growth
- UGRO N/A
- DRMA N/A
- EPS
- UGRO N/A
- DRMA N/A
- Revenue
- UGRO $59,985,133.00
- DRMA N/A
- Revenue This Year
- UGRO N/A
- DRMA N/A
- Revenue Next Year
- UGRO $31.25
- DRMA N/A
- P/E Ratio
- UGRO N/A
- DRMA N/A
- Revenue Growth
- UGRO N/A
- DRMA N/A
- 52 Week Low
- UGRO $0.29
- DRMA $0.66
- 52 Week High
- UGRO $1.92
- DRMA $5.00
- Technical
- Relative Strength Index (RSI)
- UGRO 49.87
- DRMA 44.67
- Support Level
- UGRO $0.29
- DRMA $0.66
- Resistance Level
- UGRO $0.42
- DRMA $0.75
- Average True Range (ATR)
- UGRO 0.03
- DRMA 0.05
- MACD
- UGRO 0.01
- DRMA 0.00
- Stochastic Oscillator
- UGRO 76.92
- DRMA 44.50
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.